预防中风的低剂量胆固醇:系统性审查和元分析的系统概述
Giovani Noll1, Wyllians Vendramini Borelli2, Gabriel Paulo Mantovani3
1Department of Neurology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil; Faculty of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
科尔奇辛在减少中风复发方面表现有前途,但可能会增加胃肠道问题. 为了制定最终的中风预防指南,还需要进一步的研究.
科学领域:
- 心血管研究研究心血管研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 尽管预防方面取得了进展,中风仍然是全球重要的健康问题.
- 科尔奇辛正在成为预防中风的潜在治疗剂.
研究的目的:
- 系统地审查和综合用于预防中风的菌素的疗效和安全性数据.
- 总结随机对照试验 (RCT) 的系统审查和元分析 (SRMA) 的发现.
主要方法:
- 根据PRISMA指南对SRMA进行了概述.
- 在PubMed,Embase和Cochrane图书馆进行了搜索.
- 统计分析包括使用I2统计数据进行异质性评估.
主要成果:
- 胆固醇显著降低了中风复发率 (RR 0.46),没有异质性 (I2 = 0%).
- 胃肠道不良事件增加了 (RR 1.54,I2 = 63%).
- 大多数SRMA显示中风发病率降低,但也报告了增加的GI事件;整体SRMA质量有显著差异.
结论:
- 中等质量的证据表明,在高风险群体中,黄素为预防中风提供了好处和可接受的安全性.
- 在分析的研究中,中风并不总是主要的终点.
- 需要高质量的RCT,专门设计用于用菌素预防中风.
更多相关视频
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
08:53Assessing Neuroprotective Effects of Glycyrrhizae Radix et Rhizoma Extract Using a Transient Middle Cerebral Artery Occlusion Mouse Model
Published on: December 9, 2018
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Drugs for Treatment of Ulcerative Colitis in IBD
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Alzheimer's Disease: Treatment
